Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategy
about
Antimicrobial proteins in intestine and inflammatory bowel diseasesHIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationshipsThe antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease.The role of the antimicrobial peptide cathelicidin in renal diseases.Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo.Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial.Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosisBoosting innate immunity: development and validation of a cell-based screening assay to identify LL-37 inducers.The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus.Human polymorphisms as clinical predictors in leprosyPhenylbutyrate Is Bacteriostatic against Mycobacterium tuberculosis and Regulates the Macrophage Response to Infection, Synergistically with 25-Hydroxy-Vitamin D3.Concurrent Pneumonia in Children Under 5 Years of Age Presenting to a Diarrheal Hospital in Dhaka, Bangladesh.Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial.Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans.Regulation of antimicrobial peptide gene expression by nutrients and by-products of microbial metabolism.Butyrate upregulates endogenous host defense peptides to enhance disease resistance in piglets via histone deacetylase inhibition.Beneficial Effects of Sodium Phenylbutyrate Administration during Infection with Salmonella enterica Serovar Typhimurium.Potent Inducers of Endogenous Antimicrobial Peptides for Host Directed Therapy of Infections.Avian antimicrobial host defense peptides: from biology to therapeutic applications.Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based TherapiesAntimicrobial peptides important in innate immunity.Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections.Antimicrobial peptides and colitis.Antimicrobial peptide elicitors: new hope for the post-antibiotic era.Immunotherapy for pulmonary TB: antimicrobial peptides and their inducers.Unique features of human cathelicidin LL-37.Update on clinical and research application of fecal biomarkers for gastrointestinal diseases.Epithelial ER Stress in Crohn's Disease and Ulcerative Colitis.Cyclic mechanical stretch down-regulates cathelicidin antimicrobial peptide expression and activates a pro-inflammatory response in human bronchial epithelial cells.Treatment with Entinostat Heals Experimental Cholera by Affecting Physical and Chemical Barrier Functions of Intestinal Epithelia.High Throughput Screening for Natural Host Defense Peptide-Inducing Compounds as Novel Alternatives to Antibiotics.
P2860
Q27023239-8598D781-6E51-4B61-866D-C15674108ED9Q28731648-59707760-CEE3-455F-83F6-E689B49E7E25Q33403877-E0B4C9E2-372A-4FEB-959E-796C1CBDF56FQ33417340-EEE27C0C-B08B-47DC-980E-207016648EFEQ33700171-90C63DAC-71FB-4EF5-B95B-7CBCBA6D9BD4Q34265202-79445C94-FCD6-4262-8E48-2661A64FFF1BQ34670730-BD01BD8A-C151-4AC6-827F-E42D0B5A5504Q34864069-9D7948D1-5495-4146-BFBE-31E209C7F747Q34983753-16322293-3CB2-48FA-9D36-C206B8ADAA9EQ35636319-F0341EA3-5650-4FE0-9BE6-115984D69A12Q35680478-958B7CCC-C5EF-49D9-A9D0-4E0F57DA2D20Q35684778-17197E85-CF65-43E5-88E0-36188C335A61Q35783492-49ABFD55-BB0E-4119-8139-7146727507C9Q36650606-6D64CF80-F7E8-4B1B-A548-7D7B967ACF67Q36655079-E0D51208-0F5F-4767-8CA3-AB804194B723Q36941333-5DECBF66-DF7B-472F-9BF4-43619CD5783FQ37199789-FF040466-2732-40F8-93BC-AF0E243F2433Q37402593-3D7195FA-654C-4DC2-B84C-4D7135205B76Q37689800-89141605-A7A2-4C3A-B57D-5C0E90033655Q37727501-8B795FB5-798E-407C-BDD9-65CA1693A704Q37919159-35927570-9AB9-4D88-B37B-9813CE5CC717Q38018928-8AA7BF38-B740-46A6-8971-F0821447A3E9Q38040831-F29CC1D2-8D5D-4FC6-8E26-61369CE6D920Q38060524-42C0009D-193A-445F-B026-6701EDC55BE4Q38148589-17B4458D-B374-4C4C-A891-11E15BD3DC14Q38598753-C6D7CE19-5F4A-4AB0-9F6F-474BD1994881Q38755379-3DBC81D5-632A-4E5C-B6FD-472925734069Q38763648-97F6203D-E50D-4C78-8E55-1CF1C08D275CQ38811891-4929EAB4-FB24-4D6E-93BD-27E82B8E589EQ40239307-F367277E-A05B-4C2F-93CA-371E73643D73Q55267196-26A893F8-9EE5-4B44-805D-CEF5F5B2720C
P2860
Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategy
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phenylbutyrate counteracts Shi ...... potential therapeutic strategy
@ast
Phenylbutyrate counteracts Shi ...... potential therapeutic strategy
@en
Phenylbutyrate counteracts Shi ...... potential therapeutic strategy
@nl
type
label
Phenylbutyrate counteracts Shi ...... potential therapeutic strategy
@ast
Phenylbutyrate counteracts Shi ...... potential therapeutic strategy
@en
Phenylbutyrate counteracts Shi ...... potential therapeutic strategy
@nl
prefLabel
Phenylbutyrate counteracts Shi ...... potential therapeutic strategy
@ast
Phenylbutyrate counteracts Shi ...... potential therapeutic strategy
@en
Phenylbutyrate counteracts Shi ...... potential therapeutic strategy
@nl
P2093
P2860
P3181
P1433
P1476
Phenylbutyrate counteracts Shi ...... potential therapeutic strategy
@en
P2093
Gudmundur H Gudmundsson
Jan Andersson
Peter Bergman
Protim Sarker
Roger Stromberg
Rokeya Sultana Rekha
Snigdha Tiash
Sultan Ahmed
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0020637
P407
P577
2011-01-01T00:00:00Z